Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cellsRiki Okita(National Sanyo Hospital), Masao Nakata(Kawasaki Medical School)Oncology ReportsSeptember 28, 201510.3892/or.2015.4314Cited by 22SaveCiteExport RISWatch citationsRelated PapersContrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells|PLoS ONE|2015|37Characterizing soluble immune checkpoint molecules and TGF-β1,2,3 in pleural effusion of malignant pleural mesothelioma|Scientific Reports|2024|3